Kazia Therapeutics Limited
KZIA
$6.75
$0.172.58%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.75% | 40.80% | -0.20% | -105.33% | 0.47% |
| Total Depreciation and Amortization | -2.75% | 1.72% | 0.20% | 0.85% | -0.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.74% | -51.91% | 0.20% | 539.31% | -0.46% |
| Change in Net Operating Assets | 2.74% | -111.94% | 0.21% | 1,018.09% | -0.48% |
| Cash from Operations | 2.75% | -163.74% | -0.21% | 48.29% | 0.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 0.00% | -100.08% | 0.00% |
| Total Debt Repaid | -- | -- | 0.00% | 100.22% | 0.00% |
| Issuance of Common Stock | 0.00% | 656.18% | 0.00% | -72.41% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00% | 82.61% | 0.00% |
| Cash from Financing | -2.75% | 703.69% | 0.20% | -73.84% | -0.48% |
| Foreign Exchange rate Adjustments | -2.73% | -17.93% | 0.28% | 213.38% | 0.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.74% | 175.07% | -0.21% | -14.53% | 0.47% |